These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33713558)

  • 1. Establishing the protocols for the South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme for drug surveillance.
    Partridge E; Alfred S; Camilleri A; Green H; Haustead D; Kostakis C; Mallon J; Mason K; Rivers-Kennedy A; Stockham P
    Emerg Med Australas; 2021 Oct; 33(5):883-887. PubMed ID: 33713558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
    Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
    Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Drugs Network of Australia - Victoria Clinical Registry: A state-wide illicit substance surveillance and alert network.
    Syrjanen R; Schumann J; Fitzgerald J; Gerostamoulos D; Abouchedid R; Rotella JA; Knott J; Maplesden J; Hollerer H; Hannon L; Bourke E; Hodgson SE; Greene SL
    Emerg Med Australas; 2023 Feb; 35(1):82-88. PubMed ID: 36053993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An early warning system for emerging drugs of concern in the emergency department: Protocol for the Western Australian Illicit Substance Evaluation (WISE) study.
    McCutcheon D; Raghavan M; Soderstrom J; Oosthuizen F; Douglas B; MacDonald E; Fatovich D
    Emerg Med Australas; 2019 Jun; 31(3):411-416. PubMed ID: 30318770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
    Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
    Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department.
    Smith JL; Soderstrom J; Dawson A; Alfred S; Greene S; Isoardi K; McCutcheon D; Oosthuizen F; Ezard N; Burcham J; Fatovich DM;
    Emerg Med Australas; 2022 Feb; 34(1):58-64. PubMed ID: 34382338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) program: first results.
    Alfred S; Stockham P; Partridge E; Ward A; Green H; Mallon J; Kostakis C; Camilleri A; Haustead D
    Med J Aust; 2023 May; 218(8):376-377. PubMed ID: 36977652
    [No Abstract]   [Full Text] [Related]  

  • 9. Illicit drugs in the emergency department: Can we determine on clinical grounds if patients are intoxicated? Results from the Western Australian Illicit Substance Evaluation (WISE) study.
    McCutcheon D; Soderstrom J; Raghavan M; Oosthuizen F; Douglas B; Burrows S; Smith JL; Fatovich D
    Drug Alcohol Rev; 2023 Nov; 42(7):1807-1815. PubMed ID: 37587737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project.
    Syrjanen R; Schumann JL; Lyons T; McKinnon G; Hodgson SE; Abouchedid R; Gerostamoulos D; Koutsogiannis Z; Fitzgerald J; Greene SL;
    Int J Drug Policy; 2023 Dec; 122():104251. PubMed ID: 37952318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of psychoactive drugs in injured patients presenting to an emergency department.
    Isles S; McBride P; Gee P; Fleischer D; Kappatos D; Pandey R; Civil I; Gabbe B
    Emerg Med Australas; 2023 Feb; 35(1):25-33. PubMed ID: 35859101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics in new psychoactive substance users: A single center study.
    Su YJ; Chen TH; Liao WH; Chang KS; Lai YC
    Medicine (Baltimore); 2023 Jun; 102(25):e34084. PubMed ID: 37352073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering harm reduction to the community and frontline medical practitioners through the South Australian Drug Early Warning System (SADEWS).
    Camilleri A; Alfred S; Gerber C; Lymb S; Painter B; Rathjen A; Stockham P
    Forensic Sci Med Pathol; 2021 Sep; 17(3):388-394. PubMed ID: 34013465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective observational study of emergency department presentations following novel psychoactive substance use.
    Henshall DE; Innes CW; Morrison SR; Wilson B; Brown RA; McAllister SM; Culshaw SL; Reda E
    Scott Med J; 2018 May; 63(2):39-44. PubMed ID: 29514583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
    Helander A; Bäckberg M; Beck O
    PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
    Liakoni E; Dolder PC; Rentsch KM; Liechti ME
    BMC Pharmacol Toxicol; 2016 May; 17(1):25. PubMed ID: 27228985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of analytically confirmed gamma-hydroxybutyrate (GHB) positive patients in the emergency department: presentation, poly-drug use, disposition and impact on intensive care resource utilisation.
    Stockham P; Partridge E; Alfred S; Boyle L; Camilleri A; Green H; Haustead D; Humphries M; Kostakis C; Mallon J
    Clin Toxicol (Phila); 2023 Apr; 61(4):241-247. PubMed ID: 37129222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department.
    Weng TI; Chen LY; Chen JY; Chen PS; Hwa HL; Fang CC
    J Formos Med Assoc; 2020 Dec; 119(12):1827-1834. PubMed ID: 32037264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.